| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217203 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 8 Pages |
Abstract
In using IMRT to treat mediastinal lymphoma, all dosimetric parameters predicted RP, although small doses to large volumes of lung had the greatest influence. Patients with relapsed or refractory lymphoma who received salvage chemotherapy and hematopoietic stem cell transplantation were at higher risk for symptomatic RP.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chelsea C. MD, PhD, Grace L. MD, PhD, Sarah MD, Eleanor M. MD, Jay P. MD, PhD, Mani MD, Valerie MD, Isidora MD, Pamela K. PhD, Christine F. MS, Michele A. MD, Yasuhiro MD, Francesco MD, Jorge MD, Luis MD, Nathan MD, Jason MD, Loretta MD, Bouthaina MD,